psychedelic drugs
-
Anthony Tennyson of Awakn Life Sciences on commercializing its addiction treatment therapeutics
In this InvestorIntel interview with host Tracy Weslosky, Awakn Life Sciences Corp.’s (NEO: AWKN | OTCQB: AWKNF) Co-Founder &…
-
The light at the end of the tunnel for Awakn Life Sciences addiction treatment by Psychedelic therapeutics
As an investor, I like to look for companies that have tremendous leverage to success. I often write…
-
FSD Pharma, Developing Treatments for Mental Health Disorders
In a recent InvestorIntel interview, Tracy Weslosky spoke with Anthony Durkacz, Founder, Interim CEO and Executive Co-Chairman of…
-
Awakn announces first-ever study investigating ketamine in gambling addiction treatment
When we think about addiction many people think about drugs, tobacco, and alcohol addiction; but often forget about…
-
Newly listed Awakn Life Sciences’ team of experts prepare a pathway to treat addiction through psychedelic medicines
One of the largest problems in our society today is substance abuse and addiction. Almost 21 million Americans…
